Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bedrocan Cannabis Corp. V.BED

Healthcare Biotechnology


TSXV:BED - Post by User

Bedrocan Cannabis Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by PotStockeron Feb 26, 2015 1:27am
134 Views
Post# 23466666

Revenue projection for Bed.v

Revenue projection for Bed.v
 Revenue Projection       Million $ Increase rate Number of patients Notes
2014 Q3 0.49   1400 Let us assume the revenue increase at 13% for Q4 2014 to Q2 2015
2014 Q4 0.55 13% 1582  
2015 Q1 0.63   1788  
2015 Q2 0.71   2270 Let us assume the revenue increase at 27.5% for after Q2 2015 because of domestic production
2015 Q3 0.90 27% 2883  
2015 Q4 1.14   3662  
2016 Q1 1.45   4651  
2016 Q2 1.84   5906 It is the break even quater.

Note, the green prints are my speculation based on other LPs in the same sector.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities